COLL COLLEGIUM PHARMACEUTICAL INC US FDA Inspections 8-K Filing 2024 - FDA Exclusivity Granted Collegium Pharmaceutical, Inc. announces FDA granting pediatric exclusivity for Nucynta and Nucynta ER, extending exclusivity of the Nucynta Franchise.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC